Assessing the efficacy of treatments for panic disorder and agoraphobia. II. The Panic and Agoraphobia Scale.
about
Early detection and treatment of panic disorder with or without agoraphobia: updateExercise as Treatment for Anxiety: Systematic Review and Analysis.Commonalities and differences in the neural substrates of threat predictability in panic disorder and specific phobia.Does D-cycloserine enhance exposure therapy for anxiety disorders in humans? A meta-analysis.Efficacy of a hybrid online training for panic symptoms and agoraphobia: study protocol for a randomized controlled trial.Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder.Gender-specific association of galanin polymorphisms with HPA-axis dysregulation, symptom severity, and antidepressant treatment response.The weight of cognitions in panic: the link between misinterpretations and panic attacks.A feasibility study of the clinical effectiveness and cost-effectiveness of individual cognitive behavioral therapy for panic disorder in a Japanese clinical setting: an uncontrolled pilot study.Orbito-frontal cortex volumes in panic disorderInternet addiction and problematic Internet use: A systematic review of clinical research.Abnormal activity-dependent brain lactate and glutamate+glutamine responses in panic disorder.Comparing physical exercise in groups to group cognitive behaviour therapy for the treatment of panic disorder in a randomized controlled trial.Cortisol awakening response in drug-naïve panic disorder.The GABA transporter 1 (SLC6A1): a novel candidate gene for anxiety disorders.Factors associated with pain level in non-cardiac chest pain patients with comorbid panic disorder.Evaluation of a practice team-supported exposure training for patients with panic disorder with or without agoraphobia in primary care - study protocol of a cluster randomised controlled superiority trial.Changes in cerebral blood flow after cognitive behavior therapy in patients with panic disorder: a SPECT study.Hippocampal neurochemical pathology in patients with panic disorder.Temperament, character traits, and alexithymia in patients with panic disorder.Anxiety Associated Increased CpG Methylation In The Promoter of Asb1: A Translational Approach Evidenced By Epidemiological And Clinical Studies And A Murine Model.Two Novel Cognitive Behavioral Therapy-Based Mobile Apps for Agoraphobia: Randomized Controlled Trial.Early Improvement and Marriage Are Determinants of the 12-Month Treatment Outcome of Paroxetine in Outpatients with Panic Disorder.Polymorphism in Tmem132d regulates expression and anxiety-related behavior through binding of RNA polymerase II complex.Does cognitive behavioral therapy alter mental defeat and cognitive flexibility in patients with panic disorder?Stress hormone response to the DEX-CRH test and its relation to psychotherapy outcome in panic disorder patients with and without agoraphobia.
P2860
Q24653681-D5BD2B97-A927-4287-A5F5-98FB8349B18EQ27693304-7BD47FE1-CA83-4CE6-8173-E2300874C716Q30360562-A93147E4-0362-4602-AA15-66C45BBF3771Q31171981-9BF2A21A-545A-4386-BE4F-5185560D26D7Q33441998-E11DC3F3-B0C7-4705-9B3C-C5509668C0F0Q34238795-2FDF5E16-50B1-4436-BE9B-19B8B540E9F1Q34661003-7B2DA1BA-3442-499C-B7B7-82726F2871A6Q34934939-C03E8FF5-A4AD-4E1A-B08F-4FCAF1984E4FQ36158129-254988FD-A1E5-4E7E-95F5-95512494746EQ36463515-C9D084EC-E4EF-42A7-AB2D-DC6F75D1D676Q36719411-8A1F9448-01E3-48C9-93D7-92054822435AQ36794591-4172994E-1512-4E64-BF5A-28AFBC12CE1EQ36910360-EA5B6454-F8BC-4249-B9FD-22B056BB22A6Q37058778-CB15D87F-A56D-4318-919E-E5C7D9577EBEQ37223768-1A5F2538-FC26-40DF-9108-1120689A9170Q37349928-93ECF666-E5B3-48AB-982B-4AC0674A9996Q37698271-29850217-00D7-4CE6-83EE-AA7B7FE79D4FQ37724193-68DED1A9-634F-4D91-9906-DECD39872D1AQ39600987-6E325BAE-3614-44B7-BA04-BEDB8DF1BD03Q40022486-8C62DF9C-E1B1-44DA-A839-DDF5F13181B9Q40187016-3EBC36D6-351D-45B0-B45C-FF07BE6C3B7AQ47123719-8779C785-80FB-4009-BBA7-26143D4EBAA6Q47163599-3E38715C-111F-4775-8569-9ABB541FEABDQ47556292-F49A5ABB-D59E-4860-8BAF-A84F8E6CCBC3Q47556429-17B56FB1-5380-4AD6-8DD9-A905E25678E3Q49390216-A92A227E-80AA-4762-9FF5-B529084C33B3
P2860
Assessing the efficacy of treatments for panic disorder and agoraphobia. II. The Panic and Agoraphobia Scale.
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Assessing the efficacy of trea ...... e Panic and Agoraphobia Scale.
@ast
Assessing the efficacy of trea ...... e Panic and Agoraphobia Scale.
@en
Assessing the efficacy of trea ...... e Panic and Agoraphobia Scale.
@nl
type
label
Assessing the efficacy of trea ...... e Panic and Agoraphobia Scale.
@ast
Assessing the efficacy of trea ...... e Panic and Agoraphobia Scale.
@en
Assessing the efficacy of trea ...... e Panic and Agoraphobia Scale.
@nl
prefLabel
Assessing the efficacy of trea ...... e Panic and Agoraphobia Scale.
@ast
Assessing the efficacy of trea ...... e Panic and Agoraphobia Scale.
@en
Assessing the efficacy of trea ...... e Panic and Agoraphobia Scale.
@nl
P1476
Assessing the efficacy of trea ...... he Panic and Agoraphobia Scale
@en
P2093
Bandelow B
P577
1995-06-01T00:00:00Z